Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • AXTI vs GSK✓SelectedUSD · GSKAXTI vs GSK performance historyLatest closeAs of-2.22%11/18
Stock and ETF performance explorer

AXTI vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+259.7%
GSK return
+7.0%
Excess return
+252.7%
Maximum drawdown
-74.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.2%-1.3%-0.9%-3.0%
7D-24.2%-3.1%-21.1%-25.6%
30D-37.3%-0.9%-36.4%-37.2%
3M-56.7%-4.2%-52.6%-56.4%
6M-66.4%-1.6%-64.8%-66.0%
YTD+117.8%+2.6%+115.2%+118.7%
1Y+259.7%+6.2%+253.5%+265.9%
All+259.7%+7.0%+252.7%+265.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling